MBOAT7 in liver and extrahepatic diseases
MBOAT7 is a protein anchored to endomembranes by several transmembrane domains. It
has a catalytic dyad involved in remodelling of phosphatidylinositol with polyunsaturated …
has a catalytic dyad involved in remodelling of phosphatidylinositol with polyunsaturated …
Membrane-bound O-acyltransferase 7 (MBOAT7)-driven phosphatidylinositol remodeling in advanced liver disease
V Varadharajan, WJ Massey, JM Brown - Journal of Lipid Research, 2022 - ASBMB
Advanced liver diseases account for approximately 2 million deaths annually worldwide.
Roughly, half of liver disease-associated deaths arise from complications of cirrhosis and …
Roughly, half of liver disease-associated deaths arise from complications of cirrhosis and …
[HTML][HTML] LPIAT1/MBOAT7 contains a catalytic dyad transferring polyunsaturated fatty acids to lysophosphatidylinositol
Human membrane bound O-acyltransferase domain-containing 7 (MBOAT7), also known as
lysophosphatidylinositol acyltransferase 1 (LPIAT1), is an enzyme involved in the acyl-chain …
lysophosphatidylinositol acyltransferase 1 (LPIAT1), is an enzyme involved in the acyl-chain …
Functional and Structural Changes in the Membrane-Bound O-Acyltransferase Family Member 7 (MBOAT7) Protein: The Pathomechanism of a Novel MBOAT7 …
J Lee, A Shamim, J Park, JH Jang, JH Kim… - Frontiers in …, 2022 - frontiersin.org
The membrane-bound O-acyltransferase domain-containing 7 (MBOAT7) gene is
associated with intellectual disability, early onset seizures, and autism spectrum disorders …
associated with intellectual disability, early onset seizures, and autism spectrum disorders …
[HTML][HTML] Identification of novel loss of function variants in MBOAT7 resulting in intellectual disability
The membrane bound O-acyltransferase domain-containing 7 (MBOAT7) gene codes for an
enzyme involved in regulating arachidonic acid incorporation in lysophosphatidylinositol …
enzyme involved in regulating arachidonic acid incorporation in lysophosphatidylinositol …
Clinical and genetic characterization of patients segregating variants in KPTN, MINPP1, NGLY1, AP4B1, and SON underlying neurodevelopmental disorders …
A Ullah, AA Shah, M Alluqmani… - International Journal …, 2022 - Wiley Online Library
Neurodevelopmental disorders (NDDs) are heterogeneous genetic conditions of the central
nervous system (CNS). Primary phenotypes of NDDs include epilepsy, loss of …
nervous system (CNS). Primary phenotypes of NDDs include epilepsy, loss of …
Loss of the immunomodulatory transcription factor BATF2 in humans is associated with a neurological phenotype
Epilepsy and mental retardation are known to be associated with pathogenic mutations in a
broad range of genes that are expressed in the brain and have a role in neurodevelopment …
broad range of genes that are expressed in the brain and have a role in neurodevelopment …
Phospholipid Acyltransferases: Characterization and Involvement of the Enzymes in Metabolic and Cancer Diseases
J Korbecki, M Bosiacki, M Pilarczyk… - Cancers, 2024 - mdpi.com
Simple Summary This review discusses the enzymatic processes governing the initial
stages of the synthesis of glycerophospholipids (phosphatidylcholine …
stages of the synthesis of glycerophospholipids (phosphatidylcholine …
Overlapping neurological phenotypes in two extended consanguineous families with novel variants in the CNTNAP1 and ADGRG1 genes
Background Population diversity is important and rare disease isolates can frequently reveal
novel homozygous or biallelic mutations that lead to expanded clinical heterogeneity, with …
novel homozygous or biallelic mutations that lead to expanded clinical heterogeneity, with …
A patient with novel MBOAT7 variant: The cerebellar atrophy is progressive and displays a peculiar neurometabolic profile
M Farnè, GM Tedesco, C Bedetti… - American Journal of …, 2020 - Wiley Online Library
Mutations in the MBOAT7 gene have been described in 43 patients, belonging to 18
families, showing nonspecific clinical features (intellectual disability [ID], seizures …
families, showing nonspecific clinical features (intellectual disability [ID], seizures …